澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ADALTA LTD

0.003

0.000

成交量：50.00萬

成交額：1,500

市值：963.65萬

市盈率：-1.30

高：0.003

開：0.003

低：0.003

收：0.003

52周最高：0.050

52周最低：0.003

股本：32.12億

流通股本：24.61億

量比：1.24

換手率：0.02%

股息：- -

股息率：- -

每股收益(TTM):-0.002

每股收益(LYR):-0.002

淨資產收益率：-628.72%

總資產收益率：-142.26%

市淨率：26.03

市盈率(LYR):-1.30

資料載入中...

總覽公司新聞資訊公告

Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄將Iro平台引入澳大利亞及亞太市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/1AD.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","market":"AU","secType":"STK","nameCN":"ADALTA LTD","latestPrice":0.003,"timestamp":1789452720000,"preClose":0.003,"halted":0,"volume":500000,"delay":0,"changeRate":0,"nameEN":"ADALTA LTD","floatShares":2461369466,"shares":3212169000,"eps":-0.0023,"marketStatus":"未開盤","change":0,"latestTime":"09-15 16:12:00 AEST","open":0.003,"high":0.003,"low":0.003,"amount":1500,"amplitude":0,"askPrice":0.004,"askSize":11875019,"bidPrice":0.003,"bidSize":43864476,"shortable":3,"etf":0,"ttmEps":-0.0023,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.003,"openAndCloseTimeList":[[1789430400000,1789452000000]],"volumeRatio":1.2394879035854867,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AD.AU","preClose":0.003,"auctionPrice":0.003,"auctionVolume":45000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789452012904}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AD.AU\",,,,,undefined,":{"symbol":"1AD.AU","floatShares":2461369466,"roa":"-142.26%","roe":"-628.72%","lyrEps":-0.0023,"volumeRatio":1.2394879035854867,"shares":3212169000,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.003,"pbRate":"26.03","psRate":"23.84","week52High":0.05,"institutionHeld":0,"latestPrice":0.003,"committee":0.57391,"eps":-0.0023,"divideRate":0,"volume":500000,"delay":0,"ttmEps":-0.0023,"open":0.003,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.003,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AD.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-12-09","symbol":"1AD.AU","defaultRemindTime":1765234800000,"type":"split","dateTimestamp":1765198800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2021-12-17","symbol":"1AD.AU","defaultRemindTime":1639695600000,"type":"split","dateTimestamp":1639659600000,"forFactor":990277,"toFactor":1000000,"ratio":0.990277},{"market":"AU","date":"2020-08-13","symbol":"1AD.AU","defaultRemindTime":1597276800000,"type":"split","dateTimestamp":1597240800000,"forFactor":981818,"toFactor":1000000,"ratio":0.981818}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AD.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128114587","title":"Adalta攜手Oribiotech與Cell Therapies簽署諒解備忘錄 將Iro平台引入澳大利亞及亞太市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1128114587","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128114587?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 07:20","pubTimestamp":1776727255,"startTime":"0","endTime":"0","summary":"澳大利亚生物技术公司Adalta Ltd与合作伙伴Oribiotech、Cell Therapies共同签署了一份具有战略意义的谅解备忘录。该协议旨在将创新的Iro技术平台推广至澳大利亚及亚太地区。\n这一合作标志着三方在细胞治疗领域的深度协同。通过资源整合与技术共享，合作伙伴计划加速Iro平台在亚太市场的商业化进程，为当地医疗健康产业注入新的技术活力。\n此次布局不仅展现了Adalta Ltd在全球生物技术领域的战略眼光，也预示着亚太地区将成为细胞治疗技术发展的重要增长极。合作各方将共同探索该技术在不同医疗场景中的应用潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AD.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}